Drug Database · Clinicians

L-alanyl-l-glutamine

Brands (4) Alamine, Dipeptiven, Elemune…Show all

Part of: Parenteral nutrition products (Drug Index, by product type)

Amino acid; Parenteral nutrition PH FDA category

Rx · Prescription drug4 PH products PN kidney notes reviewed
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
US label not yet available for this generic. Check the Philippine package insert (linked in the products table where the FDA has published one).

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney-specific guidance from renalcarematters.com: in preparation.

Parenteral nutrition: kidney notes

Brand-specific kidney notes for the parenteral nutrition products filed under this generic: composition from the manufacturer SmPC or package insert, its kidney-related text, and how the product fits the guideline. Sources are listed under References.

Kidney notes: Dipeptiven

Dipeptiven (Fresenius Kabi Austria GmbH) is a concentrated N(2)-L-alanyl-L-glutamine solution, a glutamine dipeptide added to parenteral or enteral nutrition in hypercatabolic or hypermetabolic states. Philippine registration: 100 ml glass bottles.

Composition

Per presentationper 100 ml
N(2)-L-alanyl-L-glutamine (g)20
L-alanine (g)8.2
L-glutamine (g)13.46
  • Theoretical osmolarity 921 mOsmol/l; pH 5.4 to 6.0 (SmPC). These amounts match the Philippine registration (20 g/100 ml, equivalent to L-alanine 8.2 g and L-glutamine 13.46 g).

Composition from the cited manufacturer SmPC/package insert; values independently re-checked November 17, 2026.

Dose and rate limits

  • 0.3 to 0.5 g alanyl-glutamine/kg body weight per day (1.5 to 2.5 ml/kg); maximum 2.5 ml/kg/day; must not exceed 30% of total amino acid/protein supply; not more than 3 weeks (SmPC 4.2).

Kidney notes

  • Contraindicated in severe renal insufficiency (creatinine clearance below 25 ml/min), severe hepatic insufficiency, circulatory shock, hypoxia, multiple organ failure and severe metabolic acidosis (SmPC 4.3).
  • Monitor serum electrolytes, serum osmolality, fluid balance, acid-base balance, creatinine clearance, urea and liver function tests (SmPC 4.4).

How it fits the ESPEN 2021 kidney nutrition guideline

  • ESPEN 2021 Recommendation 28: "In critically ill patients with AKI, AKI on CKD, or CKD with KF, additional high dose parenteral glutamine shall not be administered." Grade of recommendation A – Strong consensus (100% agreement).

Bottom line

Do not use in critically ill patients with AKI (acute kidney injury), AKI on CKD (chronic kidney disease) or CKD with kidney failure (ESPEN Rec 28, Grade A); outside critical illness, the SmPC contraindicates it when creatinine clearance is below 25 ml/min.

Not shown here

  • The Philippine package insert was not available to compare; check it before use.

renalcarematters.com notes, reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. Check the current Philippine package insert before use. renalcarematters.com, reviewed

Dosage forms

Philippines

  • Solution for intravenous infusion: 200 mg/mL
  • ) concentrate for solution for iv infusion: 20 g/100 mL (equivalent to L-alanine 8.2 g, L-glutamine 13.46 g per 100 mL
  • Solution for iv infusion: 200 mg/mL

Registered products in the Philippines

4 products registered with the Food and Drug Administration (FDA) Philippines list L-alanyl-l-glutamine as the generic name (including products registered under a variant spelling). Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Also registered under: N(2)- L-alanyl- L-glutamine (1 product). Products registered under these spellings are included in the table and marked.

Verify on PH FDA portal

All registered products4
Philippine FDA-registered products for L-alanyl-l-glutamine
Package insert
AlamineL-Alanyl-L-Glutamine
200 mg / mL Solution for Intravenous (I.V.) InfusionUSP Type II Clear Glass Vial with Bromobutyl Rubber Stopper and Flip Off Seal x 50mL (Box of 1 Vial)
Rx
Aculife Healthcare Private LimitedIndia
Biocare Lifesciences, Inc.Importer: Blue Global (FZE)
DRP-14818-01
Jan 17, 2029
DipeptivenN(2)- L-alanyl- L-glutamineVariant spelling
20g/100mL (equivalent to L-alanine 8.2 g, L-glutamine 13.46 g per 100 mL) Concentrate for Solution for IV InfusionHydrolytic Resistance Type II, colourless glass bottle x 100 mL (Box of 10's)
Rx
Fresenius Kabi Austria GmbHAustria
Fresenius Kabi Philippines, Inc.
DR-XY26736
Mar 22, 2027
ElemuneL-Alanyl-L-Glutamine
200 mg/mL (20% w/v) Solution for IV InfusionType II USP Glass Vial x 100 mL Box of 1's
Rx
OTSUKA PHARMACEUTICAL INDIA PRIVATE LIMITEDIndia
OTSUKA (PHILIPPINES) PHARMACEUTICAL, INC.
DR-XY42020
May 16, 2028
GlutariteL-Alanyl-L-Glutamine
200 mg/mL Solution for Intravenous (I.V.) InfusionUSP Type II Clear Glass Vial with Bromobutyl Rubber Stopper and Flip Off Seal x 50 mL (Box of 1 vial)
Rx
Aculife Healthcare Private Limited.India
Blue Global (FZE)
DRP-14818
Jan 17, 2029

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
  2. Fresenius Kabi. (2023). Dipeptiven 200 mg/ml concentrado para solución para perfusión [Ficha técnica (summary of product characteristics); text revised June 2023; Spanish]. Agencia Española de Medicamentos y Productos Sanitarios (CIMA). https://cima.aemps.es/cima/dochtml/ft/61771/FT_61771.html
  3. Fiaccadori, E., Sabatino, A., Barazzoni, R., Carrero, J. J., Cupisti, A., De Waele, E., Jonckheer, J., Singer, P., & Cuerda, C. (2021). ESPEN guideline on clinical nutrition in hospitalized patients with acute or chronic kidney disease. Clinical Nutrition, 40(4), 1644–1668. https://doi.org/10.1016/j.clnu.2021.01.028

renalcarematters.com content: Parenteral nutrition kidney notes (Dipeptiven): reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .